Invention Grant
- Patent Title: Absorption enhancers for intranasal administration
- Patent Title (中): 鼻内给药的吸收增强剂
-
Application No.: US13371274Application Date: 2012-02-10
-
Publication No.: US08927497B2Publication Date: 2015-01-06
- Inventor: Edward T. Maggio
- Applicant: Edward T. Maggio
- Applicant Address: US CA San Diego
- Assignee: Aegis Therapeutics, LLC.
- Current Assignee: Aegis Therapeutics, LLC.
- Current Assignee Address: US CA San Diego
- Agency: DLA Piper LLP (US)
- Main IPC: A61P25/08
- IPC: A61P25/08 ; C07G3/00

Abstract:
A composition including a surfactant and at least one alkyl glycoside and/or saccharide alkyl ester and a drug. The surfactant composition(s) when admixed with a drug is non-toxic and non-irritating, while stabilizing and increasing the bioavailability of the drug. The invention also provides compositions that enhance absorption of drugs via the oral, ocular, nasal, nasolacrimal, inhalation or pulmonary, oral cavity (sublingual or Buccal cell) or CSF delivery route of a patient, including but not limited to insulin, glucagon and exendin-4.
Public/Granted literature
- US20120196941A1 ABSORPTION ENHANCERS FOR DRUG ADMINISTRATION Public/Granted day:2012-08-02
Information query